← Back to Search

Multilevel Connection Tool for Cancer Patients

N/A

Waitlist Available

Led By Janice Krieger, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within two months of consent

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a tool to help Black and Hispanic cancer patients & families get referrals to cancer treatment centers.

Who is the study for?

This trial is for Black and Hispanic adults aged 18 to 73 in Florida, who can read English or Spanish at an eighth-grade level, are willing to be re-contacted, and have email or text capabilities. It's aimed at those underrepresented in cancer clinical trials.

What is being tested?

The study tests a tailored ALEX Research Portal with a virtual Community Health Educator against a stand-alone portal to help guide these populations through referrals to cancer clinical trials.

What are the potential side effects?

Since this trial involves the use of informational portals rather than medical interventions, there are no direct physical side effects associated with participating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 2 months of consent

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 2 months of consent

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 months of consent for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of patients who self-refer to cancer clinical trials

Secondary study objectives

Change in trust in Cancer Clinical Trials

Mediators of intervention effectiveness

Virtual Clinical Health Education (vCHE) preferences

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Stand-alone PortalExperimental Treatment1 Intervention

The standard of care condition will include a portal that provides patients with access to existing online cancer clinical trial resources in one location. This includes links to pages with basic information about cancer clinical trials, ongoing studies, enrollment opportunities for existing institutional research registries, and contact information for study coordinators.

Group II: Portal with Virtual Community Health Educator (vCHE)Experimental Treatment1 Intervention

The virtual community health educator condition will provide all information in standard of care with the addition of a virtual community health educator. Patients will have the opportunity to choose which virtual community health educator will provide digital navigation. The choices will include at least four English-speaking and four Spanish-speaking virtual community health educators representing different genders and racial/ethnic backgrounds.

Do I qualify?Apply below to find out